A modified ILD-GAP index for patients with non-small cell lung cancer and interstitial lung disease

H. Kobayashi (Shizuoka, Japan), T. Naito (Shizuoka, Japan), S. Omori (Shizuoka, Japan), K. Nakashima (Shizuoka, Japan), K. Wakuda (Shizuoka, Japan), A. Ono (Shizuoka, Japan), H. Kenmotsu (Shizuoka, Japan), H. Murakami (Shizuoka, Japan), M. Endo (Shizuoka, Japan), T. Takahashi (Shizuoka, Japan)

Source: International Congress 2018 – Lung cancer: personalised medicine
Session: Lung cancer: personalised medicine
Session type: Poster Discussion
Number: 2227
Disease area: Thoracic oncology

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
H. Kobayashi (Shizuoka, Japan), T. Naito (Shizuoka, Japan), S. Omori (Shizuoka, Japan), K. Nakashima (Shizuoka, Japan), K. Wakuda (Shizuoka, Japan), A. Ono (Shizuoka, Japan), H. Kenmotsu (Shizuoka, Japan), H. Murakami (Shizuoka, Japan), M. Endo (Shizuoka, Japan), T. Takahashi (Shizuoka, Japan). A modified ILD-GAP index for patients with non-small cell lung cancer and interstitial lung disease. 2227

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Do cavitating non-small cell lung cancer patients have a more aggressive disease?
Source: Eur Respir J 2006; 28: Suppl. 50, 84s
Year: 2006

A study on chemotherapy induced interstitial lung disease in patients with unresectable non-small cell lung cancer complicated by combined pulmonary fibrosis and emphysema
Source: Annual Congress 2012 - Treatment of lung cancer
Year: 2012


Does the lung function affect the survival time in patients with resected non-small cell lung cancer?
Source: Annual Congress 2007 - Lung function parameters before and after thoracic surgery
Year: 2007


Changes of lung function in patients with non-small cell lung cancer tretaed by chemotherapy
Source: Eur Respir J 2006; 28: Suppl. 50, 771s
Year: 2006

How to handle oligometastatic disease in nonsmall cell lung cancer
Source: Eur Respir Rev, 30 (159) 200234; 10.1183/16000617.0234-2020
Year: 2021



Tumour infiltrating lymphocytes and tumour associated macrophages in chronic obstructive pulmonary disease (COPD) patients with non-small cell lung cancer (NSCLC) and in patients with NSCLC
Source: Eur Respir J 2005; 26: Suppl. 49, 92s
Year: 2005

Non-small cell lung cancer resected molecular expression in COPD and low function pulmonary patients
Source: Annual Congress 2007 - Biology, diagnosis and rare tumours in thoracic malignancies
Year: 2007


Clinicopathologic features of patients with non-small cell lung cancer and chronic obstructive pulmonary disease undergoing lung cancer surgery
Source: Virtual Congress 2020 – Localised non-small cell lung cancer
Year: 2020


Management of brain metastases in patients with non-small cell lung cancer
Source: International Congress 2017 – Lung cancer - clinical research: scientific pearls from the bedside
Year: 2017


Lung cancer
Source: Respipedia Article
Year: 2018

Influence of the lung resection to small airways function in patients with limited and normal lung function and primary non-small cell lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 718s
Year: 2006

Detecting extrathoracic metastases in patients with non-small cell lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 41s
Year: 2006

Advanced non-small cell lung cancer in elderly patients
Source: Breathe 2012; 9: 26-34
Year: 2012

Radio(chemo)therapy in locally advanced nonsmall cell lung cancer
Source: Eur Respir Rev 2015; 25: 65-70
Year: 2016



Comparing exhaled molecular profiles of patients with non-small cell lung cancer (NSCLC) with those of patients with non-pulmonary malignancy
Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease
Year: 2010

Physical Activity patients following lung resection for non-small cell lung cancer
Source: International Congress 2017 – Latest insights into functional capacity, muscle weakness and physical activity in chronic lung diseases
Year: 2017


Influence of histological subtypes of bronchioloalveolar carcinoma on prognosis and treatment
Source: Annual Congress 2006 - Prognostic factors in lung cancer
Year: 2006


Expression analysis of miR-223 in plasma of patients with non-small cell lung cancer and other obstructive lung diseases
Source: International Congress 2018 – Lung cancer: novel prognostic markers and scores
Year: 2018


Metastatic disease in non-small cell lung cancer: is it all the same?
Source: International Congress 2017 – Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up
Year: 2017

Effect of comorbidity on the prognosis of non-small cell lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 385s
Year: 2006